Hopital Calmette
About Hopital Calmette
"Hôpital public à Lille"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University Hospital, Lille
20
Boehringer Ingelheim
9
Intergroupe Francophone de Cancerologie Thoracique
8
Vertex Pharmaceuticals Incorporated
3
Actelion
2
Alexion
2
Amgen
2
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
2
Canadian Cancer Trials Group
2
Hoffmann-La Roche
2
University Hospital, Tours
2
Clinical Trials at Hopital Calmette
During the past decade, Hopital Calmette conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 14 clinical trials were completed, i.e. on
average, 31.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 5 clinical trials were completed. i.e. 27.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation
2003-05-01
2006-04-01
Completed
901
Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders
2000-10-01
2003-10-01
Completed
1,000
Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis
2001-10-01
2004-04-01
Terminated
120
Correction of Anaemia and Progression of Renal Failure on Transplanted Patients
2004-04-01
2010-05-01
Completed
128
Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation
2008-10-01
2011-10-01
Unknown status
64
Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)
2010-06-25
2016-09-26
Completed
198
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hopital Calmette" #1 sponsor was "University Hospital, Lille" with 20 trials, followed by "Boehringer Ingelheim" with 9 trials
sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 8 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 3 trials sponsored and "Actelion"
with 3 trials sponsored. Other sponsors include 22 different institutions and
companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Calmette"
#1 collaborator was "Roche Pharma AG" with 4 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator, "Institut Pasteur de Lille" with 2 trials as a collaborator, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator and "Santelys Association" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were
collaborators in the rest 36 trials.
Clinical Trials Conditions at Hopital Calmette
According to Clinical.Site data, the most researched conditions in "Hopital Calmette" are
"Cystic Fibrosis" (8 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials), "Idiopathic Pulmonary Fibrosis" (5 trials), "Lung Cancer" (4 trials) and "Asthma" (3 trials). Many other conditions were trialed in "Hopital Calmette" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Calmette
Most popular intervention types in "Hopital Calmette" are "Drug" (42 trials), "Other" (9 trials), "Device" (4 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Nintedanib" (6 trials), "Pemetrexed" (5 trials), "Carboplatin" (3 trials) and "ELX/TEZ/IVA" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Calmette
The vast majority of trials in "Hopital Calmette" are
68 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hopital Calmette
Currently, there are NaN active trials in "Hopital Calmette".
undefined are not yet recruiting,
18 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 31 completed trials in Hopital Calmette,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Calmette, 0 "Phase 1"
clinical trials were conducted, 18 "Phase 2" clinical
trials and 22 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 9 trials that are defined as “Not Applicable".